Results 81 to 90 of about 53,802 (245)

Different distribution of breast cancer subtypes in breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion

Zhongguo aizheng zazhi, 2018
Background and purpose: Breast ductal carcinoma in situ with microinvasion (DCIS-MI) is considered to be the interim stage in the progression from breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC).
李　爽, 郎冠天, 余科达
doaj  

Peptide‐based responsive molecular fluorescent probes for precision oncology

Responsive Materials, EarlyView.
Peptide‐based responsive fluorescent probes have emerged as adaptive functional materials for precision tumor theranostics, combining tumor‐selective recognition, programmable stimulus responsiveness, and modular tunability. They enable high‐contrast imaging, intraoperative guidance, real‐time monitoring, and multimodal applications, while next ...
Xing Wang, Wen Liu, Jiahao Zhang, Wanqi Wang, Zhicheng Jin, Yuqi Tang, Quan Li   +6 more
wiley   +1 more source

Biomaterial‐Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation

Small, EarlyView.
Biomaterial‐integrated electroporation establishes a programmable therapeutic interface that coordinates electric‐field modulation, transient or irreversible membrane permeabilization, cargo stabilization, and immune remodeling. This Review highlights how nanocarriers, hydrogels, and bioelectronic interfaces expand electroporation from conventional ...
Binbin Ji, Zhuozhuo Wu, Yuyue Jiang, Xiaoyu Liu, Jingfeng Li, Fengkuo Xu, Chaojie Li, Qungang Shan, Ziyin Wang, Junhao Wang, Wei Huang, Yaping Zhuang, Wenguo Cui, Zhongmin Wang   +13 more
wiley   +1 more source

Ductal Carcinoma in situ of the female Breast

, 2007
The breast is the most common site of cancer in females in many parts of the world. Mammary carcinoma is either ductal arising from ducts or lobular arising from lobules.
Mohammadani, A.A., Mohamed, Elgaili, Elkhatim, Mukhtar   +2 more
core  

Postoperative tamoxifen for ductal carcinoma in situ (protocol)

, 2009
The aim of this review is to assess the effectiveness of postoperative tamoxifen in women having surgical resection of ductal carcinoma in situ (DCIS)
McCallum, Iain, Craig, Wendy, Bruce, J. (Julie)   +2 more
core   +1 more source

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast [PDF]

, 2015
Ductal carcinoma in situ is a biologically diverse entity. Whereas some lesions are cured by local surgical excision, others recur as in situ disease or progress to invasive carcinoma with subsequent potential for metastatic spread.
Pang, JMB, Campbell, IG, Dobrovic, A, Gorringe, KL, Wong, SQ, Fox, SB   +5 more
core   +1 more source

CARCINOMA DUCTAL IN SITU: GENERALIDADES, DIAGNÓSTICO, TRATAMIENTO Y CONTROVERSIAS

Revistas Argentina de Medicina, 2018
El carcinoma ductal in situ (CDIS) constituye, en lugar de una sola entidad, un grupo heterogéneo de lesiones con diferente potencial de malignidad y se lo considera un verdadero precursor del cáncer.
Carlos E Muñoz Medina, Luis D Alemán Frías, Milvis P Fleitas Moreno, Lizbeth B Tovar Duque, Irene Alvez, Oscar A Hurtado Patiño, Jairo Basetta, Milgaris P Fleitas Moreno, Elvis Polanco   +8 more
doaj   +2 more sources

Whole‐transcriptome sequencing analyses identified exosomal circular RNAs in the plasma of pancreatic cancer patients as novel blood‐based biomarkers of disease

VIEW, EarlyView.
Pancreatic cancer (PaCa) has a poor prognosis, with low resection rates and high relapse rates, highlighting the urgent need for novel diagnostic biomarkers. Here, we performed whole‐transcriptome sequencing of plasma‐derived exosomes from PaCa patients and identified several differentially expressed circular RNAs (circRNAs).
Xiaomeng He, Yang Di, Lixiang Sun, Zhirong Wu, Mengting Luo, Xin Zhang, Huaqin Sun, Wanli Xu, Wenchuan Wu, Boheng Zhang, Jin Wang   +10 more
wiley   +1 more source

Clinicopathological analysis of ductal carcinoma in situ(DCIS) and ductal carcinoma in situ with microinvasion

, 2000
The natural history of the patients of ductal carcinoma in situ(DCIS) with microinvasion is poorly defined, and the clinical management of these patients with particular reference to management of the axilla, has been controversial.
박병우
core  

Tamoxifen Initiation After Ductal Carcinoma In Situ

, 2016
Endocrine therapy initiation after ductal carcinoma in situ (DCIS) is highly variable and largely unexplained. National guidelines recommend considering tamoxifen for women with estrogen receptor-positive (ER+) DCIS or who undergo excision alone.
Bowles, Erin J. A., Buist, Diana S. M., Nichols, Hazel B., Islam, Jessica, Stürmer, Til, Tran, Diem-Thy, Madziwa, Lawrence   +6 more
core   +1 more source